. Author manuscript; available in PMC: 2015 Mar 1.

Published in final edited form as: Ann Allergy Asthma Immunol. 2014 Jan 7;112(3):211–216.e1. doi: 10.1016/j.anai.2013.12.006

Table 1.

Patient Demographics and Pulmonary Function

Group Parameter	Control (CTL)	Steroid-Sensitive (SS)	Steroid-Resistant (SR)	P value
No. of subjects	10	5	4
Age (yrs) (mean±SD)	32.7±11.0	30.6±6.5	35.5±9.9
Sex (M/F)	5:5	3:2	2:2
Race	Cauc (8), Asian (2)	Cauc (4), Hisp(1)	Cauc (2), Hisp(1), AFAM(1)
Average positive skin prick tests (range)	0	5.6+ (4+~9+)	5.0+ (1+~10+)
Serum total IgE (IU/mL) (range)	76 (2~377)	177 (86~409)	333 (56~589)^*	<0.05^*
Prebronchodilator FEV1 % predicted (mean±SD) Postbronchodilator	95.1±10.2	75.8±8.2^*	65.8±8.2^*	<0.05^*
	104.4±10.6	89.8±9.9	79.5±13.0	<0.05^*
FVC % predicted (mean±SD) Prebronchodilator Postbronchodilator	99.2±3.9	90.8±10.1	88.5±19.8	NS
	99.2±5.9	97.4±12.5	97.8±26.1	NS
FEV1/FVC Prebronchodilator Postbronchodilator	0.82±0.03	0.70±0.05	0.63±0.06	<0.05^*
FEV1/FVC Prebronchodilator Postbronchodilator	0.86±0.05	0.78±0.08	0.69±0.08	<0.05^*
% Lvmphocvtes in BAL expressing: BLT1⁺CD8⁺ BLT1⁺CD8⁺IL-13⁺	13.97±1.6 4.78±1.2	25.32±3.4 13.4±3.7	34.2±5.1 16.5±2.3	<0.05^* <0.05^*

Compared to controls.

Cauc: Caucasian, Hisp: Hispanic, AFAM: African American.